CB24296-3 - 0x0000000000003784

Study Number: CB24296
Group Number: 3
Study Requirement: Healthy Male and Female
Stipend: $3,010.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 18.5 - 32
  • Weight Restriction: minimum weight 111 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Inflammatory Bowel Disease.
  • Route of Administration: Oral
  • Blood Draws: 32

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: One - 10 Night Stay & 1 Phone Call

Screening Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Thursday 9/6/2018
Monday 9/10/2018

Doctor Exam Dates: (appointments available in Lincoln and Omaha)

Event Day Event Date
Thursday 9/6/2018
Monday 9/10/2018

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 9/19/2018 2:00:00 PM Saturday 9/29/2018 7:15:00 AM 1 Lincoln
Phone participant* Wednesday 10/3/2018 10:00:00 AM 1 Lincoln